Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

On Location

Updates from major medical meetings in the field of hematology/oncology
On Location Video Interviews
AML MRD Testing By NGS Identifies Adults At High Relapse Risk After Allogeneic Transplantation
Addition of Ibrutinib to Standard Therapy Improves PFS in Older Patients With MCL
Anti-Coagulation Therapy Compliance Poor in Cancer-Associated VTE
Venetoclax Combination Therapy Works Better in Some AML Subtypes Than Others
Elranatamab Results in 61% ORR in Patients With R/R MM in Phase II Study
Women Underrepresented as Authors in Prestigious Cancer Trials
Glofitamab Produces Durable Responses in DLBCL
MajesTEC-1 Results Show Teclistamab Elicits Durable Responses in Patients With R/R MM
Oncology Fellows Benefit from Condensed Learning Resources and Engaged Learning
Momelotinib Bests Danazol in Symptomatic Patients With Anemic Myelofibrosis
Rusfertide Therapy for Polycythemia Vera Leads to Sustained Hematocrit Control
Roxadustat Increases Hemoglobin in Patients With Anemia Receiving Myelosuppressive Chemotherapy
Patient-Tailored Therapeutic Strategies Needed in Newly Diagnosed MM
Magrolimab Plus Azacitidine Elicits Response in Untreated, Higher Risk MDS
Factors That May Increase Thrombosis Risk in AML Identified
Long-Term Bleeding Prophylaxis Found Cost-Effective for VWD
SRSF2 Mutation Status May Predict Romiplostim Treatment Response in Lower-Risk MDS
BCMA-Directed CAR-T Therapy Effective in Relapsed/Refractory Multiple Myeloma
High-Precision, Allogeneic Cell Therapy Improves Survival in Patients With Hematologic Malignancies

Advertisement

Connect with us:

CURRENT ISSUE
September 2022

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright ©2022 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement